Hyoun-Ah Kim1, Lina Seo2, Ju-Yang Jung1, Ye Won Kim1, Eunyoung Lee3, Sun-Mi Cho4, Chang-Hee Suh5. 1. Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea. 2. Department of Psychiatry, Ajou University School of Medicine, Suwon, South Korea. 3. Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea. 4. Department of Psychiatry, Ajou University School of Medicine, Suwon, South Korea. Electronic address: smcho@ajou.ac.kr. 5. Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea. Electronic address: chsuh@ajou.ac.kr.
Abstract
BACKGROUND: and purpose: The stress and systemic lupus erythematosus (SLE) are intertwined and affecting each other. This pilot study evaluated the mindfulness-based cognitive therapy (MBCT) in Korean patients with SLE. MATERIALS AND METHODS: The Korean version of the Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Satisfaction with Life Scale (SWLS), and Perceived Stress Scale (PSS) were evaluated for the effect of the MBCT in 25 patients. RESULTS: The BDI-II, BAI, SWLS, and PSS before the MBCT were 24.2 ± 10.6, 19.1 ± 9.7, 14.7 ± 6.5, and 20.4 ± 3.8, respectively. Eighteen patients completed the MBCT. After the MBCT, BDI-II, BAI, and PSS improved to 17.4 ± 13.0 (p < 0.01), 13.4 ± 7.7 (p = 0.04), and 17.9 ± 4.6 (p = 0.04), respectively. However, SWLS and SLE disease activity did not. CONCLUSION: The MBCT could reduce the anxiety, depression, and stress but not SLE disease activity.
BACKGROUND: and purpose: The stress and systemic lupus erythematosus (SLE) are intertwined and affecting each other. This pilot study evaluated the mindfulness-based cognitive therapy (MBCT) in Korean patients with SLE. MATERIALS AND METHODS: The Korean version of the Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Satisfaction with Life Scale (SWLS), and Perceived Stress Scale (PSS) were evaluated for the effect of the MBCT in 25 patients. RESULTS: The BDI-II, BAI, SWLS, and PSS before the MBCT were 24.2 ± 10.6, 19.1 ± 9.7, 14.7 ± 6.5, and 20.4 ± 3.8, respectively. Eighteen patients completed the MBCT. After the MBCT, BDI-II, BAI, and PSS improved to 17.4 ± 13.0 (p < 0.01), 13.4 ± 7.7 (p = 0.04), and 17.9 ± 4.6 (p = 0.04), respectively. However, SWLS and SLE disease activity did not. CONCLUSION: The MBCT could reduce the anxiety, depression, and stress but not SLE disease activity.